Renaissance Technologies
MTNB icon

Renaissance Technologies’s Matinas BioPharma MTNB Stock Holding History

Renaissance Technologies’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.5K Buy
4,736
+2,831
+149% +$27.4K ﹤0.01% 3058
2026
Q1 		$14.3K Sell
1,905
-26
-1% -$244 ﹤0.01% 3188
2025
Q4 		$17K Buy
1,931
+46
+2% +$813 ﹤0.01% 3154
2025
Q3 		$53.4K Buy
1,885
+240
+15% +$5.17K ﹤0.01% 3333
2025
Q2 		$22K Buy
1,645
+154
+10% +$1.69K ﹤0.01% 3466
2025
Q1 		$11.6K Buy
1,491
+280
+23% +$2.49K ﹤0.01% 3387
2024
Q4 		$9.27K Buy
+1,211
New +$27.6K ﹤0.01% 3521
2024
Q3 		– Sell
-596
Closed -$70.8K – 3764
2024
Q2 		$70.8K Buy
596
+44
+8% +$5.98K ﹤0.01% 3243
2024
Q1 		$112K Buy
552
+56
+11% +$9.98K ﹤0.01% 3348
2023
Q4 		$80K Buy
496
+210
+73% +$35.6K ﹤0.01% 3359
2023
Q3 		$28K Buy
286
+91
+47% +$16.8K ﹤0.01% 3482
2023
Q2 		$53K Sell
195
-34
-15% -$11.9K ﹤0.01% 3605
2023
Q1 		$81K Buy
229
+68
+42% +$25.8K ﹤0.01% 3551
2022
Q4 		$61K Buy
161
+116
+258% +$57.9K ﹤0.01% 3761
2022
Q3 		$21K Buy
+45
New +$26.5K ﹤0.01% 3892
2021
Q3 		– Sell
-812
Closed -$472K – 3709
2021
Q2 		$472K Buy
812
+625
+334% +$403K ﹤0.01% 2985
2021
Q1 		$147K Sell
187
-1,439
-88% -$1.45M ﹤0.01% 3190
2020
Q4 		$1.66M Buy
+1,626
New +$1.13M ﹤0.01% 2233
2020
Q3 		– Sell
-356
Closed -$206K – 3568
2020
Q2 		$206K Sell
356
-1,010
-74% -$581K ﹤0.01% 3149
2020
Q1 		$615K Buy
1,366
+969
+244% +$878K ﹤0.01% 2657
2019
Q4 		$676K Buy
+397
New +$345K ﹤0.01% 2790
2019
Q2 		– Sell
-337
Closed -$276K – 3688
2019
Q1 		$276K Buy
+337
New +$272K ﹤0.01% 3120
2018
Q4 		– Sell
-180
Closed -$124K – 3524
2018
Q3 		$124K Buy
180
+138
+329% +$44.5K ﹤0.01% 3222
2018
Q2 		$14K Buy
+42
New +$18.2K ﹤0.01% 3222

Other funds holding MTNB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HIW
Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Renaissance Technologies's MTNB Position: Q2 2026 in Review

Renaissance Technologies increased its Matinas BioPharma (MTNB) stake by 149% in Q2 2026, buying an estimated $27.4K and bringing the position to 4,736 shares worth $43.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3058.

Renaissance Technologies first reported a position in MTNB in Q2 2018 and has held it in 24 quarters since. The position peaked at $1.66M in Q4 2020. 23 funds tracked by Wall St. Rank hold MTNB as of Q2 2026.

  • Renaissance Technologies held 4,736 shares of Matinas BioPharma worth $43.5K as of Q2 2026.
  • Renaissance Technologies bought 2,831 Matinas BioPharma shares in Q2 2026, an estimated $27.4K.
  • Matinas BioPharma made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3058 holding.
  • Renaissance Technologies first reported a position in Matinas BioPharma in Q2 2018 and has held it in 24 quarters since.
  • Renaissance Technologies's Matinas BioPharma position peaked at $1.66M in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.